Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,792 | 2,969 | 3,011 | 2,918 | 3,394 |
| Marketable Securities | N/A | 3,158 | N/A | 3,379 | N/A |
| Other current assets | 3,448 | 110 | 3,462 | 274 | 3,535 |
| TOTAL | $6,240 | $6,237 | $6,473 | $6,571 | $6,929 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | N/A | 2 | N/A |
| Intangibles | 0 | 380 | 0 | 380 | 0 |
| Other Non-Current Assets | 381 | 0 | 382 | 0 | 382 |
| TOTAL | $381 | $381 | $382 | $382 | $382 |
| Total Assets | $6,621 | $6,618 | $6,855 | $6,953 | $7,311 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 260 | 231 | 0 | 258 | 251 |
| TOTAL | $260 | $231 | $185 | $258 | $251 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 517 | 1,054 | 3,591 | 3,413 | 2,693 |
| TOTAL | $517 | $1,054 | $3,591 | $3,413 | $2,693 |
| Total Liabilities | $777 | $1,285 | $3,776 | $3,671 | $2,944 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 14,120 | N/A | 13,603 | N/A |
| Retained earnings | N/A | -155,133 | N/A | -156,447 | N/A |
| Other shareholders' equity | 5,844 | 20 | 3,079 | 20 | 4,367 |
| TOTAL | $5,844 | $5,333 | $3,079 | $3,282 | $4,367 |
| Total Liabilities And Equity | $6,621 | $6,618 | $6,855 | $6,953 | $7,311 |